Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TITLE, Lawrence M")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes : An effect prevented by vitamins C and ETITLE, Lawrence M; CUMMINGS, Peter M; GIDDENS, Karen et al.Journal of the American College of Cardiology. 2000, Vol 36, Num 7, pp 2185-2191, issn 0735-1097Article

Microvascular Function Predicts Cardiovascular Events in Primary Prevention: Long-Term Results From the Firefighters and Their Endothelium (FATE) StudyANDERSON, Todd J; CHARBONNEAU, Francois; TITLE, Lawrence M et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 2, pp 163-169, issn 0009-7322, 7 p.Article

Optimal medical therapy with or without PCI for stable coronary diseaseBODEN, William E; O'ROURKE; CHAITMAN, Bernard R et al.The New England journal of medicine. 2007, Vol 356, Num 15, pp 1503-1516, issn 0028-4793, 14 p.Article

The effect of iron status on vascular healthYUNKER, Leanne M; PARBOOSINGH, Jillian S; ANDERSON, Todd J et al.Vascular medicine (London). 2006, Vol 11, Num 2, pp 85-91, issn 1358-863X, 7 p.Article

The relationship between soluble CD40 ligand levels and framingham coronary heart disease risk score in healthy volunteersVERMA, Subodh; WANG, Chao-Hung; LI, Shu-Hong et al.Atherosclerosis. 2005, Vol 182, Num 2, pp 361-365, issn 0021-9150, 5 p.Article

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease. CommentaryTITLE, Lawrence M; GIDDENS, Karen; MCINERNEY, Michele M et al.Journal of the American College of Cardiology. 2003, Vol 42, Num 10, pp 1747-1756, issn 0735-1097, 10 p.Article

Comparison of New Measures of Vascular Function to Flow Mediated Dilatation as a Measure of Cardiovascular Risk FactorsPHILPOTT, Andrew C; LONN, Eva; TITLE, Lawrence M et al.The American journal of cardiology. 2009, Vol 103, Num 11, pp 1610-1615, issn 0002-9149, 6 p.Article

Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trialTARDIF, Jean-Claude; GREGOIRE, Jean; SCOTT, Rob et al.Atherosclerosis. 2008, Vol 197, Num 1, pp 480-486, issn 0021-9150, 7 p.Article

The Canadian Study of the Sirolimus-Eluting Stent in the Treatment of Patients With Long De Novo Lesions in Small Native Coronary Arteries (C-SIRIUS). CommentarySCHAMPAERT, Erick; COHEN, Eric A; SCHLÜTER, Michael et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 6, pp 1110-1117, issn 0735-1097, 8 p.Article

Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial)DUPUIS, Jocelyn; TARDIF, Jean-Claude; WOO, Anna et al.The American journal of cardiology. 2005, Vol 96, Num 9, pp 1207-1213, issn 0002-9149, 7 p.Article

Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individualsVERMA, Subodh; WANG, Chao-Hung; LONN, Eva et al.European heart journal. 2004, Vol 25, Num 19, pp 1754-1760, issn 0195-668X, 7 p.Article

  • Page / 1